日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer

靶向 Syndecan-1 的治疗性抗体可抑制巨胞饮作用,并在胰腺癌中诱导抗肿瘤免疫。

Zecheng Yang,Madelaine S Theardy,Shuaitong Chen,Yongkun Wei,Mitsunobu Takeda,Yue Zeng,Xiaofei Wang,Jun Yao,Jennifer Li,Prapassorn Thirasastr,Jangho Park,Yangxi Zheng,Long T Vien,Khalida M Wani,Huamin Wang,Sisi Gao,Tim Heffernan,Lawrence Kwong,Ignacio I Wistuba,Laura Bover,Giulio F Draetta,Haoqiang Ying,Wantong Yao

Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations

同种型对激动剂抗 OX40 抗体在癌症中的作用机制的影响:对治疗组合的启示

Jane E Willoughby, Lang Dou, Sabyasachi Bhattacharya, Heather Jackson, Laura Seestaller-Wehr, David Kilian, Laura Bover, Kui S Voo, Kerry L Cox, Tom Murray, Mel John, Hong Shi, Paul Bojczuk, Junping Jing, Heather Niederer, Andrew J Shepherd, Laura Hook, Stephanie Hopley, Tatyana Inzhelevskaya, Chris

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas

嵌合抗原受体 T 细胞靶向 B 细胞淋巴瘤中的 CD79b

Fuliang Chu, Jingjing Cao, Jingwei Liu, Haopeng Yang, Timothy J Davis, Shao-Qing Kuang, Xiaoyun Cheng, Zheng Zhang, Swathi Karri, Long T Vien, Laura Bover, Ryan Sun, Francisco Vega, Michael Green, Richard Eric Davis, Sattva S Neelapu

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

基于KIR的抑制性CAR可克服CAR-NK细胞吞噬作用介导的同胞相残和肿瘤逃逸。

Ye Li,Rafet Basar,Guohui Wang,Enli Liu,Judy S Moyes,Li Li,Lucila N Kerbauy ,Nadima Uprety,Mohsen Fathi,Ali Rezvan,Pinaki P Banerjee,Luis Muniz-Feliciano,Tamara J Laskowski,Emily Ensley,May Daher,Mayra Shanley,Mayela Mendt,Sunil Acharya,Bin Liu,Alexander Biederstädt,Hind Rafei,Xingliang Guo,Luciana Melo Garcia,Paul Lin,Sonny Ang,David Marin,Ken Chen,Laura Bover ,Richard E Champlin,Navin Varadarajan,Elizabeth J Shpall,Katayoun Rezvani

B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade

B细胞是产生最佳抗黑色素瘤免疫反应(针对免疫检查点阻断疗法)所必需的。

Shubhra Singh ,Jason Roszik ,Neeraj Saini ,Vipul Kumar Singh ,Karishma Bavisi ,Zhiqiang Wang ,Long T Vien ,Zixi Yang ,Suprateek Kundu ,Richard E Davis ,Laura Bover ,Adi Diab ,Sattva S Neelapu ,Willem W Overwijk ,Kunal Rai ,Manisha Singh

Generation and Validation of an Anti-Human PANK3 Mouse Monoclonal Antibody

抗人 PANK3 鼠单克隆抗体的制备及验证

Sunada Khadka, Long Vien, Paul Leonard, Laura Bover, Florian Muller

Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death

开发和表征可保护T细胞免受半乳糖凝集素-9诱导的细胞死亡的抗半乳糖凝集素-9抗体

Riyao Yang ,Linlin Sun ,Ching-Fei Li ,Yu-Han Wang ,Weiya Xia ,Boning Liu ,Yu-Yi Chu ,Laura Bover ,Long Vien ,Mien-Chie Hung

Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo

新型 BAFF 受体抗体可消除体内耐药性人类 B 细胞恶性肿瘤

Hong Qin #, Guowei Wei #, Ippei Sakamaki, Zhenyuan Dong, Wesley A Cheng, D Lynne Smith, Feng Wen, Han Sun, Kunhwa Kim, Soungchul Cha, Laura Bover, Sattva S Neelapu, Larry W Kwak

Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination

溶瘤腺病毒和肿瘤靶向免疫调节疗法可改善自体癌症疫苗接种

Hong Jiang ,Yisel Rivera-Molina ,Candelaria Gomez-Manzano ,Karen Clise-Dwyer ,Laura Bover ,Luis M Vence ,Ying Yuan ,Frederick F Lang ,Carlo Toniatti ,Mohammad B Hossain ,Juan Fueyo

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens

针对白血病和淋巴瘤中的 IL11 受体:功能性配体导向研究和患者来源样本的血液病理学分析

Katja Karjalainen, Diana E Jaalouk, Carlos Bueso-Ramos, Laura Bover, Yan Sun, Akihiko Kuniyasu, Wouter H P Driessen, Marina Cardó-Vila, Cecilia Rietz, Amado J Zurita, Susan O'Brien, Hagop M Kantarjian, Jorge E Cortes, George A Calin, Erkki Koivunen, Wadih Arap, Renata Pasqualini4